According to a study published by the UKCF Gene Therapy Consortium, CFTR function increased byup to 3.7 % in lung cells from CF patients after treatmentwith the nebulized cationic lipid pGM169/GL67A, whichdelivers donor DNA from the normal CFTR gene. This evidence concerns the gene CFTR and cystic fibrosis.